Alexander Alanine

3.1k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Alexander Alanine is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alexander Alanine has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alexander Alanine's work include Neuroscience and Neuropharmacology Research (8 papers), Synthesis of heterocyclic compounds (6 papers) and Chemical Synthesis and Analysis (5 papers). Alexander Alanine is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Synthesis of heterocyclic compounds (6 papers) and Chemical Synthesis and Analysis (5 papers). Alexander Alanine collaborates with scholars based in Switzerland, Canada and Germany. Alexander Alanine's co-authors include Konrad Bleicher, Klaus Müller, Hans‐Joachim Böhm, Gerhard Trube, Gisbert Schneider, Olivier Roche, Pascal Pflimlin, Rainer E. Martin, Vincent Mutel and Anne Bourson and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Reviews Drug Discovery and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Alexander Alanine

26 papers receiving 1.3k citations

Hit Papers

Hit and lead generation: ... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hit and lead generation: beyond high-throughput screening
    2003 729 citations Konrad Bleicher, Hans‐Joachim Böhm et al. Nature Reviews Drug Discovery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alexander Alanine 753 456 363 158 143 26 1.3k
Owen B. Wallace 689 0.9× 405 0.9× 403 1.1× 146 0.9× 72 0.5× 27 1.6k
Martyn Banks 1.0k 1.4× 431 0.9× 241 0.7× 254 1.6× 266 1.9× 37 1.7k
Tina Garyantes 734 1.0× 390 0.9× 145 0.4× 155 1.0× 78 0.5× 16 1.3k
Ivanov As 944 1.3× 259 0.6× 172 0.5× 119 0.8× 84 0.6× 183 1.8k
Dejan Bojanic 1.4k 1.8× 775 1.7× 258 0.7× 308 1.9× 152 1.1× 25 2.3k
Allison K. Doak 1.1k 1.5× 813 1.8× 251 0.7× 88 0.6× 127 0.9× 14 1.8k
José S. Duca 1.1k 1.5× 817 1.8× 380 1.0× 77 0.5× 55 0.4× 56 2.1k
Brian Springthorpe 879 1.2× 589 1.3× 546 1.5× 41 0.3× 110 0.8× 8 1.8k
Gerhard Heßler 1.5k 2.0× 642 1.4× 456 1.3× 52 0.3× 229 1.6× 56 2.1k
Rajesh Devraj 951 1.3× 382 0.8× 746 2.1× 88 0.6× 129 0.9× 35 1.9k

Countries citing papers authored by Alexander Alanine

Since Specialization
Citations

This map shows the geographic impact of Alexander Alanine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Alanine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Alanine more than expected).

Fields of papers citing papers by Alexander Alanine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Alanine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Alanine. The network helps show where Alexander Alanine may publish in the future.

Co-authorship network of co-authors of Alexander Alanine

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Alanine. A scholar is included among the top collaborators of Alexander Alanine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Alanine. Alexander Alanine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Rainer E., et al.. (2014). Seamless Integration of Dose‐Response Screening and Flow Chemistry: Efficient Generation of Structure–Activity Relationship Data of β‐Secretase (BACE1) Inhibitors. Angewandte Chemie International Edition. 53(6). 1704–1708. 35 indexed citations
2.
3.
Webber, Matthew J., D.M. Grainger, Matthew Weston, et al.. (2013). Towards the enantioselective synthesis of (−)-euonyminol – preparation of a fully functionalised lower-rim model. Organic & Biomolecular Chemistry. 11(15). 2514–2514. 17 indexed citations
4.
Reutlinger, Michael, Wolfgang Guba, Rainer E. Martin, et al.. (2011). Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery. Angewandte Chemie International Edition. 50(49). 11633–11636. 34 indexed citations
5.
Reutlinger, Michael, Wolfgang Guba, Rainer E. Martin, et al.. (2011). Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery. Angewandte Chemie. 123(49). 11837–11840. 9 indexed citations
6.
Peters, Jens‐Uwe, Thomas Lübbers, Alexander Alanine, et al.. (2007). Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration. Bioorganic & Medicinal Chemistry Letters. 18(1). 262–266. 20 indexed citations
7.
Peters, Jens‐Uwe, Thomas Lübbers, Alexander Alanine, et al.. (2007). Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Structure–activity relationship elucidation. Bioorganic & Medicinal Chemistry Letters. 18(1). 256–261. 9 indexed citations
8.
Woltering, Thomas J., Geo Adam, Alexander Alanine, et al.. (2007). Synthesis and characterization of 8-ethynyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: New potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 17(24). 6811–6815. 21 indexed citations
9.
Rogers‐Evans, Mark, et al.. (2004). Identification of novel cannabinoid receptor ligands via evolutionary de novo design and rapid parallel synthesis. QSAR & Combinatorial Science. 23(6). 426–430. 19 indexed citations
10.
Alanine, Alexander, Matthias Nettekoven, Edward Roberts, & Andrew W. Thomas. (2003). Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process. Combinatorial Chemistry & High Throughput Screening. 6(1). 51–66. 38 indexed citations
11.
Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(10). 1759–1762. 11 indexed citations
12.
Alanine, Alexander, et al.. (2003). Synthesis and SAR evaluation of 1,2,4-triazoles as A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(3). 817–821. 25 indexed citations
13.
Alanine, Alexander, Anne Bourson, Bernd Büttelmann, et al.. (2003). 1-Benzyloxy-4,5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3155–3159. 21 indexed citations
14.
Bleicher, Konrad, Hans‐Joachim Böhm, Klaus Müller, & Alexander Alanine. (2003). Hit and lead generation: beyond high-throughput screening. Nature Reviews Drug Discovery. 2(5). 369–378. 729 indexed citations breakdown →
15.
Büttelmann, Bernd, Alexander Alanine, Anne Bourson, et al.. (2003). 2-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 829–832. 18 indexed citations
16.
Lachmann, Helen J., Laurence Lovat, Alexander Alanine, et al.. (2002). Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. RePEc: Research Papers in Economics. 1 indexed citations
17.
Gill, R., Alexander Alanine, Anne Bourson, et al.. (2002). Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist. Journal of Pharmacology and Experimental Therapeutics. 302(3). 940–948. 45 indexed citations
18.
Roche, Olivier, et al.. (2002). A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries. ChemBioChem. 3(5). 455–455. 134 indexed citations
19.
Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2002). 4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(18). 2615–2619. 21 indexed citations
20.
Pinard, Emmanuel, Alexander Alanine, Anne Bourson, et al.. (2001). Discovery of (R)-1-[2-Hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: A Novel NR1/2B Subtype Selective NMDA Receptor Antagonist. Bioorganic & Medicinal Chemistry Letters. 11(16). 2173–2176. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Owen B. Wallace Breakdown of academic impact, for papers by Martyn Banks Breakdown of academic impact, for papers by Tina Garyantes Breakdown of academic impact, for papers by Ivanov As Breakdown of academic impact, for papers by Dejan Bojanic Breakdown of academic impact, for papers by Allison K. Doak Breakdown of academic impact, for papers by José S. Duca Breakdown of academic impact, for papers by Brian Springthorpe Breakdown of academic impact, for papers by Gerhard Heßler Breakdown of academic impact, for papers by Rajesh Devraj
Rankless by CCL
2026